Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

Pulmonary Vein (PV) Isolation Versus Box Isolation for the Treatment of Atrial Fibrillation

Not Applicable

Completed

Conditions: Atrial Fibrillation
Radiofrequency Ablation

Interventions: Procedure: usual PV ablation
Procedure: Box isolation of pulmonary veins

First Posted Date: 2010-03-24

Last Posted Date: 2010-03-24

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 30

Registration Number: NCT01091597

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy

Phase 1

Completed

Conditions: Peanut Hypersensitivity
Food Hypersensitivity
Immediate Hypersensitivity

Interventions: Drug: Peanut powder
Drug: Peanut extract
Drug: Placebo powder
Drug: Placebo extract

First Posted Date: 2010-03-10

Last Posted Date: 2017-04-07

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 21

Registration Number: NCT01084174

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Memantine in Adult Autism Spectrum Disorder

Not Applicable

Terminated

Conditions: Pervasive Developmental Disorder NOS
Autism
Asperger's Disorder

Interventions: Drug: Placebo
Drug: memantine

First Posted Date: 2010-03-02

Last Posted Date: 2017-07-26

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 4

Registration Number: NCT01078844

Locations: 🇺🇸
Johns Hopkins Bayview, Baltimore, Maryland, United States

Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study

Phase 2

Completed

Conditions: Diabetic Macular Edema

Interventions: Drug: ranibizumab

First Posted Date: 2010-03-01

Last Posted Date: 2017-04-28

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 152

Registration Number: NCT01077401

Locations: 🇺🇸
Retina Vitreous Associates, Beverly Hills, California, United States
🇺🇸
University of California San Diego, LaJolla, California, United States
🇺🇸
Doheny Eye Institute, Los Angeles, California, United States

and more 10 locations

Left Ventricular Structural Predictors of Sudden Cardiac Death

Recruiting

Conditions: Nonischemic Cardiomyopathy
Ischemic Cardiomyopathy

First Posted Date: 2010-02-26

Last Posted Date: 2025-01-13

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 400

Registration Number: NCT01076660

Locations: 🇺🇸
Christiana Care Health Services, Newark, Delaware, United States
🇺🇸
Johns Hopkins Medical Institutions, Baltimore, Maryland, United States

Global Vascular Effects of Intermittent Pneumatic Compression-Pilot Study

Not Applicable

Completed

Conditions: Coronary Heart Disease

Interventions: Device: Intermittent pneumatic compression of the lower extremities

First Posted Date: 2010-02-08

Last Posted Date: 2017-08-17

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 10

Registration Number: NCT01064323

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Sleep Apnea Treatment With Expiratory Resistance(Provent™)

Phase 1

Completed

Conditions: Sleep Apnea, Obstructive

Interventions: Device: Treatment sleep study (Provent™ device used)
Other: Baseline sleep study (No device)
Other: Physiology sleep study (Provent™ on/off)

First Posted Date: 2010-02-03

Last Posted Date: 2013-07-19

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 12

Registration Number: NCT01061476

Locations: 🇺🇸
Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, United States

Intensive Care Unit (ICU) Sleep Quality and Neurocognitive Performance

Not Applicable

Completed

Conditions: Neurobehavioral Manifestations
Sleep Deprivation
Dyssomnias

Interventions: Behavioral: Sleep promoting interventions

First Posted Date: 2010-02-03

Last Posted Date: 2011-06-23

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 88

Registration Number: NCT01061242

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Effect of Seminal Fluid on the Colon Wall; Implications for HIV Transmission

Not Applicable

Completed

Conditions: Human Immunodeficiency Virus (HIV)

Interventions: Biological: Radiolabeled autologous seminal fluid
Biological: Radiolabeled Normosol-R

First Posted Date: 2010-01-21

Last Posted Date: 2017-05-25

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 11

Registration Number: NCT01053741

Locations: 🇺🇸
Johns Hopkins University Drug Development Unit, Baltimore, Maryland, United States

Drug Interaction Study With Ribavirin and Abacavir in Male Subjects With Hepatitis C Who Have Failed Ribavirin Treatment

Phase 1

Completed

Conditions: Hepatitis C
HIV

Interventions: Drug: Ribavirin plus Abacavir (ABC)
Drug: Ribavirin

First Posted Date: 2010-01-20

Last Posted Date: 2017-05-01

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 26

Registration Number: NCT01052701

Locations: 🇺🇸
Johns Hopkins Drug Development Unit, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy